Top Cited Articles
Acceptance rate:
12%
Time to first decision with review:
23 days*
Impact Factor (JCR):
23.1
Impact Factor rank (JCR):
5/143
Citescore:
45.7
Total Altmetric mentions:
6,947
Gut microbiome and health: mechanistic insights
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation
Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide
Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
A faecal microbiota signature with high specificity for pancreatic cancer
Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis
Lactobacillus rhamnosus GG induces cGAS/STING-dependent type I interferon and improves response to immune checkpoint blockade
Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis
Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Advancing human gut microbiota research by considering gut transit time
Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2
A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut